Several CD146‐targeting antibodies, including a fully humanized antibody (ABX‐MA1),21 a murine antibody AA98,22 and a rat TsCD146 mAb,23 have been developed for treating melanomas in preclinical models. The gene discussed is MCAM; the disease is melanoma.